The role of HGF on invasive properties and repopulation potential of human fetal hepatic progenitor cells

Experimental Cell Research

Volumn 315, Issue 19, 2009, Pages 3396-3405

  Delgado, Jean Paul ^a   Vanneaux, Valérie ^a   Branger, Julie ^a   Touboul, Thomas ^a   Sentilhes, Loïc ^b   Mainot, Sylvie ^a   Lainas, Panagiotis ^a   Leclerc, Philippe ^c   Uzan, Georges ^a   Mahieu Caputo, Dominique ^a,d   Weber, Anne ^a  

^a INSERM   (France)

^b Angers University Hospital   (France)

^c BICÊTRE HOSPITAL   (France)

^d BICHAT HOSPITAL   (France)

Author keywords

Hepatic progenitors; Invasion; Metalloproteases; Transplantation

Indexed keywords

BETA CATENIN; GELATINASE A; GELATINASE B; HERMES ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; FETUS; FETUS LIVER; HEPATIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LIVER CELL; LIVER DEVELOPMENT; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION;

MUS;

EID: 70350362376     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.07.007     Document Type: Article

References (48)

1. Grossman M., Rader D.J., Muller D.W., Kolansky D.M., Kozarsky K., Clark III B.J., Stein E.A., Lupien P.J., Brewer Jr. H.B., Raper S.E., and Wilson J.M. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat. Med. 1 (1995) 1148-1154
2. Fox I.J., and Roy-Chowdhury J. Hepatocyte transplantation. J. Hepatol. 40 (2004) 878-886
3. Selden C., and Hodgson H. Cellular therapies for liver replacement. Trans. Immunol. 12 (2004) 273-288
4. Fisher R.A., and Strom S.C. Human hepatocyte transplantation: worldwide results. Transplantation 82 (2006) 441-449
5. Rajvanshi P., Kerr A., Bhargava K.K., Burk R.D., and Gupta S. Studies of liver repopulation using the dipeptidyl peptidase IV-deficient rat and other rodent recipients: cell size and structure relationships regulate capacity for increased transplanted hepatocyte mass in the liver lobule. Hepatology (Baltimore, Md) 23 (1996) 482-496
6. Gupta S., Rajvanshi P., Sokhi R., Slehria S., Yam A., Kerr A., and Novikoff P.M. Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium. Hepatology (Baltimore, Md) 29 (1999) 509-519
7. Laconi E., and Laconi S. Principles of hepatocyte repopulation. Sem. Cell Dev. Biol. 13 (2002) 433-438
8. Zhao R., and Duncan S.A. Embryonic development of the liver. Hepatology (Baltimore, Md) 41 (2005) 956-967
9. Lemaigre F., and Zaret K.S. Liver development update: new embryo models, cell lineage control, and morphogenesis. Curr. Opin. Gen. Dev. 14 (2004) 582-590
10. Nierhoff D., Ogawa A., Oertel M., Chen Y.Q., and Shafritz D.A. Purification and characterization of mouse fetal liver epithelial cells with high in vivo repopulation capacity. Hepatology (Baltimore, Md) 42 (2005) 130-139
11. Oertel M., Menthena A., Dabeva M.D., and Shafritz D.A. Cell competition leads to a high level of normal liver reconstitution by transplanted fetal liver stem/progenitor cells. Gastroenterology 130 (2006) 507-520 quiz 590
12. Malhi H., Irani A.N., Gagandeep S., and Gupta S. Isolation of human progenitor liver epithelial cells with extensive replication capacity and differentiation into mature hepatocytes. J. Cell Sci. 115 (2002) 2679-2688
13. Lazaro C.A., Croager E.J., Mitchell C., Campbell J.S., Yu C., Foraker J., Rhim J.A., Yeoh G.C., and Fausto N. Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes. Hepatology (Baltimore, Md) 38 (2003) 1095-1106
14. Mahieu-Caputo D., Allain J.E., Branger J., Coulomb A., Delgado J.P., Andreoletti M., Mainot S., Frydman R., Leboulch P., Di Santo J.P., Capron F., and Weber A. Repopulation of athymic mouse liver by cryopreserved early human fetal hepatoblasts. Hum. Gene Ther. 15 (2004) 1219-1228
15. Gentile A., and Comoglio P.M. Invasive growth: a genetic program. Int. J. Dev. Biol. 48 (2004) 451-456
16. Mohammed F.F., and Khokha R. Thinking outside the cell: proteases regulate hepatocyte division. Trends Cell Biol. 15 (2005) 555-563
17. Kim T.H., Mars W.M., Stolz D.B., Petersen B.E., and Michalopoulos G.K. Extracellular matrix remodeling at the early stages of liver regeneration in the rat. Hepatology (Baltimore, Md 26 (1997) 896-904
18. Kleinman H.K., and Martin G.R. Matrigel: basement membrane matrix with biological activity. Semin. Cancer Biol. 15 (2005) 378-386
19. Zhen Z., Giordano S., Longati P., Medico E., Campiglio M., and Comoglio P.M. Structural and functional domains critical for constitutive activation of the HGF-receptor (Met). Oncogene 9 (1994) 1691-1697
20. Schmidt C., Bladt F., Goedecke S., Brinkmann V., Zschiesche W., Sharpe M., Gherardi E., and Birchmeier C. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373 (1995) 699-702
21. Pages J.C., Andreoletti M., Bennoun M., Vons C., Elcheroth J., Lehn P., Houssin D., Chapman J., Briand P., and Benarous R. Efficient retroviral-mediated gene transfer into primary culture of murine and human hepatocytes: expression of the LDL receptor. Hum. Gene Ther. 6 (1995) 21-30
22. Allain J.E., Dagher I., Mahieu-Caputo D., Loux N., Andreoletti M., Westerman K., Briand P., Franco D., Leboulch P., and Weber A. Immortalization of a primate bipotent epithelial liver stem cell. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 3639-3644
23. Calvisi D.F., Ladu S., Conner E.A., Factor V.M., and Thorgeirsson S.S. Disregulation of E-cadherin in transgenic mouse models of liver cancer. Lab. Invest.; J. Tech. Methods Pathol. 84 (2004) 1137-1147
24. Monga S.P., Monga H.K., Tan X., Mule K., Pediaditakis P., and Michalopoulos G.K. Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification. Gastroenterology 124 (2003) 202-216
25. Nelson W.J., and Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science (New York, N.Y) 303 (2004) 1483-1487
26. van der Voort R., Taher T.E., Wielenga V.J., Spaargaren M., Prevo R., Smit L., David G., Hartmann G., Gherardi E., and Pals S.T. Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J. Biol. Chem. 274 (1999) 6499-6506
27. Galardy R.E., Grobelny D., Foellmer H.G., and Fernandez L.A. Inhibition of angiogenesis by the matrix metalloprotease inhibitor N-[2R-2-(hydroxamidocarbonymethyl)-4-methylpentanoyl)]-l-tryptophan methylamide. Cancer Res. 54 (1994) 4715-4718
28. Nyormoi O., Mills L., and Bar-Eli M. An MMP-2/MMP-9 inhibitor, 5a, enhances apoptosis induced by ligands of the TNF receptor superfamily in cancer cells. Cell Death Differ. 10 (2003) 558-569
29. Trusolino L., and Comoglio P.M. Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat. Rev. 2 (2002) 289-300
30. Abiru S., Nakao K., Ichikawa T., Migita K., Shigeno M., Sakamoto M., Ishikawa H., Hamasaki K., Nakata K., and Eguchi K. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells. Hepatology (Baltimore, Md) 35 (2002) 1117-1124
31. Serandour A.L., Loyer P., Garnier D., Courselaud B., Theret N., Glaise D., Guguen-Guillouzo C., and Corlu A. TNFalpha-mediated extracellular matrix remodeling is required for multiple division cycles in rat hepatocytes. Hepatology (Baltimore, Md) 41 (2005) 478-486
32. Friedl P., Hegerfeldt Y., and Tusch M. Collective cell migration in morphogenesis and cancer. Int. J. Dev. Biol. 48 (2004) 441-449
33. Sahai E. Mechanisms of cancer cell invasion. Curr. Opin. Gen. Dev. 15 (2005) 87-96
34. Maretzky T., Reiss K., Ludwig A., Buchholz J., Scholz F., Proksch E., de Strooper B., Hartmann D., and Saftig P. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 9182-9187
35. Davies G., Jiang W.G., and Mason M.D. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin. Cancer Res. 7 (2001) 3289-3297
36. Olle E.W., Ren X., McClintock S.D., Warner R.L., Deogracias M.P., Johnson K.J., and Colletti L.M. Matrix metalloproteinase-9 is an important factor in hepatic regeneration after partial hepatectomy in mice. Hepatology (Baltimore, Md) 44 (2006) 540-549
37. Monvoisin A., Bisson C., Si-Tayeb K., Balabaud C., Desmouliere A., and Rosenbaum J. Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells. Int. J. Cancer 97 (2002) 157-162
38. Arii S., Mise M., Harada T., Furutani M., Ishigami S., Niwano M., Mizumoto M., Fukumoto M., and Imamura M. Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential. Hepatology (Baltimore, Md) 24 (1996) 316-322
39. Mohammed F.F., Pennington C.J., Kassiri Z., Rubin J.S., Soloway P.D., Ruther U., Edwards D.R., and Khokha R. Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration. Hepatology (Baltimore, Md) 41 (2005) 857-867
40. Strongin A.Y., Collier I., Bannikov G., Marmer B.L., Grant G.A., and Goldberg G.I. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270 (1995) 5331-5338
41. Dunsmore S.E., Rubin J.S., Kovacs S.O., Chedid M., Parks W.C., and Welgus H.G. Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production. J. Biol. Chem. 271 (1996) 24576-24582
42. Benten D., Kumaran V., Joseph B., Schattenberg J., Popov Y., Schuppan D., and Gupta S. Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat. Hepatology (Baltimore, Md) 42 (2005) 1072-1081
43. Paranjpe S., Bowen W.C., Bell A.W., Nejak-Bowen K., Luo J.H., and Michalopoulos G.K. Cell cycle effects resulting from inhibition of hepatocyte growth factor and its receptor c-Met in regenerating rat livers by RNA interference. Hepatology (Baltimore, Md) 45 (2007) 1471-1477
44. Orian-Rousseau V., Chen L., Sleeman J.P., Herrlich P., and Ponta H. CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev. 16 (2002) 3074-3086
45. Matzke A., Sargsyan V., Holtmann B., Aramuni G., Asan E., Sendtner M., Pace G., Howells N., Zhang W., Ponta H., and Orian-Rousseau V. Haploinsufficiency of c-Met in cd44-/- mice identifies a collaboration of CD44 and c-Met in vivo. Mol. Cell. Biol. 27 (2007) 8797-8806
46. Gargioli C., Coletta M., De Grandis F., Cannata S.M., and Cossu G. PlGF-MMP-9-expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscle. Nat. Med. 14 (2008) 973-978
47. Poyck P.P., van Wijk A.C., van der Hoeven T.V., de Waart D.R., Chamuleau R.A., van Gulik T.M., Oude Elferink R.P., and Hoekstra R. Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver. J. Hepatol. 48 (2008) 266-275
48. Nussler A., Konig S., Ott M., Sokal E., Christ B., Thasler W., Brulport M., Gabelein G., Schormann W., Schulze M., Ellis E., Kraemer M., Nocken F., Fleig W., Manns M., Strom S.C., and Hengstler J.G. Present status and perspectives of cell-based therapies for liver diseases. J. Hepatol. 45 (2006) 144-159